12:00 AM
 | 
Dec 14, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Arzerra ofatumumab regulatory update

The National Comprehensive Cancer Network (NCCN) updated its clinical practice guidelines in oncology for non-Hodgkin's lymphoma to include Arzerra ofatumumab as a treatment option for relapsed...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >